Jiayan Lian

404 total citations
10 papers, 304 citations indexed

About

Jiayan Lian is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Jiayan Lian has authored 10 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Jiayan Lian's work include RNA modifications and cancer (2 papers), interferon and immune responses (2 papers) and Cancer Mechanisms and Therapy (2 papers). Jiayan Lian is often cited by papers focused on RNA modifications and cancer (2 papers), interferon and immune responses (2 papers) and Cancer Mechanisms and Therapy (2 papers). Jiayan Lian collaborates with scholars based in China and Canada. Jiayan Lian's co-authors include Jianming Tang, Fangqiang Wei, Wenlin Xie, Haibo Zhang, Bo Yu, Xiaodong Liang, Minjun Zhang, Jianhui Wu, Shirong Zhang and Ying Wang and has published in prestigious journals such as Cell Death and Differentiation, BioMed Research International and Oncotarget.

In The Last Decade

Jiayan Lian

10 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayan Lian China 8 229 190 32 30 26 10 304
Honghong Pei China 9 209 0.9× 165 0.9× 37 1.2× 28 0.9× 29 1.1× 13 278
Zhiwei Zhao China 13 244 1.1× 178 0.9× 65 2.0× 34 1.1× 26 1.0× 29 358
Chunjuan Zhao China 9 257 1.1× 194 1.0× 46 1.4× 44 1.5× 25 1.0× 12 360
Feiye Liu China 9 213 0.9× 148 0.8× 44 1.4× 23 0.8× 19 0.7× 13 294
Yunhui Qu China 9 235 1.0× 200 1.1× 30 0.9× 20 0.7× 21 0.8× 18 317
Xiaokai Ma China 5 323 1.4× 322 1.7× 38 1.2× 22 0.7× 39 1.5× 7 410
Wenyu Wang China 8 343 1.5× 294 1.5× 33 1.0× 32 1.1× 18 0.7× 14 413
Ke Zheng China 12 314 1.4× 263 1.4× 52 1.6× 40 1.3× 21 0.8× 18 397

Countries citing papers authored by Jiayan Lian

Since Specialization
Citations

This map shows the geographic impact of Jiayan Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Lian more than expected).

Fields of papers citing papers by Jiayan Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayan Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Lian. The network helps show where Jiayan Lian may publish in the future.

Co-authorship network of co-authors of Jiayan Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayan Lian. A scholar is included among the top collaborators of Jiayan Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayan Lian. Jiayan Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tang, Jianming, Jing Li, Jiayan Lian, et al.. (2023). CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer. Journal of Advanced Research. 61. 239–251. 14 indexed citations
2.
Tang, Yi, Xiaowei Huo, Yijin Tang, et al.. (2022). MicroRNA-325-3p Targets Human Epididymis Protein 4 to Relieve Right Ventricular Fibrosis in Rats with Pulmonary Arterial Hypertension. Cardiovascular Therapeutics. 2022. 1–15. 9 indexed citations
3.
Wang, Zhuo, et al.. (2020). EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma. BioMed Research International. 2020(1). 5264265–5264265. 6 indexed citations
4.
Xie, Wenlin, Yingqiang Zhang, Bingyang Wang, et al.. (2020). Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling. Cancer Medicine. 9(17). 6367–6376. 22 indexed citations
5.
Lian, Jiayan, Haibo Zhang, Fangqiang Wei, et al.. (2019). Long non-coding RNA DANCR promotes colorectal tumor growth by binding to lysine acetyltransferase 6A. Cellular Signalling. 67. 109502–109502. 23 indexed citations
6.
Wang, Ying, Wanyuan Chen, Jiayan Lian, et al.. (2019). The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death and Differentiation. 27(2). 695–710. 158 indexed citations
7.
Dou, Chengyun, Jiayan Lian, Wen Zhou, et al.. (2018). Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis. Oncology Letters. 15(5). 8141–8148. 10 indexed citations
8.
Hu, Jun, et al.. (2016). Cartilage oligomeric matrix protein enhances the vascularization of acellular nerves. Neural Regeneration Research. 11(3). 512–512. 1 indexed citations
9.
Dou, Chengyun, Zhuo Wang, Ruhua Zhang, et al.. (2016). EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity. Oncology Reports. 35(6). 3489–3495. 40 indexed citations
10.
Lian, Jiayan, Jianming Tang, Huijuan Shi, et al.. (2015). Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Oncotarget. 6(30). 29357–29374. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026